Truscreen’s early investors sell down
Truscreen announced a capital raising on Wednesday to fund growth plans in Asia.
Several early shareholders in healthcare company Truscreen [NZX: TRU] sold down their holdings within days of the company listing last November, trading records show.
Truscreen, a marketer of cancer screening technology acquired from defunct Australian company Polartechnics, announced a capital
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Tim Hunter
Wed, 20 May 2015
Wed, 20 May 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Truscreen’s early investors sell down
47868